Table 1.

Characteristics of patients before HCT

CharacteristicData (N = 129)
Year of HCT  
 2005-2010 79 (61) 
 2011-2015 50 (39) 
Age at HCT, y  
 <1 53 (41) 
 1-1.99 40 (31) 
 2-4.99 24 (19) 
 ≥5 12 (9) 
Lansky/Karnofsky  
 Median (range) 100 (60-100) 
Family history of WAS  
 Yes 48 (37) 
 No 69 (54) 
 Unknown 12 (9) 
History of eczema before HCT  
 Yes 111 (86) 
 No 15 (12) 
 Unknown 3 (2) 
History of chronic thrombocytopenia before HCT*  
 Yes 109 (85) 
 No 13 (10) 
 Unknown 7 (5) 
History of splenectomy before HCT  
 Yes 8 (6) 
 No 121 (94) 
WAS mutations identified  
 Nonsense 30 (23) 
 Frameshift 34 (26) 
  Deletion 21 (16) 
  Insertion 12 (9) 
  Deletion/insertion 1 (1) 
 Missense 30 (23) 
 Splice site 20 (15) 
  Invariant 13 (10) 
  Variant 7 (5) 
 In-frame insertion 2 (2) 
 Large deletion 5 (4) 
 Unknown 8 (6) 
WASP expression by flow cytometry or predicted  
 Absent 83 (64) 
 Reduced 42 (33) 
 Normal 2 (1.5) 
 Unknown 2 (1.5) 
History of recurrent or severe infections before HCT  
 Yes 64 (50) 
 No 65 (50) 
History of autoimmune disease before HCT/present at time of conditioning  
 Yes 32 (25)/26 (20) 
  Thrombocytopenia 19 (15)/17 (13) 
  Hemolytic anemia 10 (8)/6 (5) 
  Neutropenia 7 (5)/5 (4) 
  Vasculitis 3 (2)/1 (1) 
  Inflammatory bowel disease 2 (2)/2 (2) 
  Arthritis 1 (1)/1 (1) 
  Nephritis 1 (1)/1 (1) 
  Alopecia 1 (1)/1 (1) 
 No 91 (70) 
 Unknown 6 (5) 
CharacteristicData (N = 129)
Year of HCT  
 2005-2010 79 (61) 
 2011-2015 50 (39) 
Age at HCT, y  
 <1 53 (41) 
 1-1.99 40 (31) 
 2-4.99 24 (19) 
 ≥5 12 (9) 
Lansky/Karnofsky  
 Median (range) 100 (60-100) 
Family history of WAS  
 Yes 48 (37) 
 No 69 (54) 
 Unknown 12 (9) 
History of eczema before HCT  
 Yes 111 (86) 
 No 15 (12) 
 Unknown 3 (2) 
History of chronic thrombocytopenia before HCT*  
 Yes 109 (85) 
 No 13 (10) 
 Unknown 7 (5) 
History of splenectomy before HCT  
 Yes 8 (6) 
 No 121 (94) 
WAS mutations identified  
 Nonsense 30 (23) 
 Frameshift 34 (26) 
  Deletion 21 (16) 
  Insertion 12 (9) 
  Deletion/insertion 1 (1) 
 Missense 30 (23) 
 Splice site 20 (15) 
  Invariant 13 (10) 
  Variant 7 (5) 
 In-frame insertion 2 (2) 
 Large deletion 5 (4) 
 Unknown 8 (6) 
WASP expression by flow cytometry or predicted  
 Absent 83 (64) 
 Reduced 42 (33) 
 Normal 2 (1.5) 
 Unknown 2 (1.5) 
History of recurrent or severe infections before HCT  
 Yes 64 (50) 
 No 65 (50) 
History of autoimmune disease before HCT/present at time of conditioning  
 Yes 32 (25)/26 (20) 
  Thrombocytopenia 19 (15)/17 (13) 
  Hemolytic anemia 10 (8)/6 (5) 
  Neutropenia 7 (5)/5 (4) 
  Vasculitis 3 (2)/1 (1) 
  Inflammatory bowel disease 2 (2)/2 (2) 
  Arthritis 1 (1)/1 (1) 
  Nephritis 1 (1)/1 (1) 
  Alopecia 1 (1)/1 (1) 
 No 91 (70) 
 Unknown 6 (5) 

Unless otherwise specified, data are the number of recipients (percentage of total study group).

*

Chronic thrombocytopenia is defined as a platelet count <100 000/μL on 2 evaluations separated by at least 3 months.

Close Modal

or Create an Account

Close Modal
Close Modal